• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804350-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stroke/CVA (1770)
Event Date 05/21/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that on the (b)(6) 2022, a percutaneous coronary intervention (pci) was performed in the mid left anterior descending artery (lad) and two non-abbott stents were implanted.On (b)(6) 2022, after confirming the lesion with the intravascular ultrasound (ivus) a percutaneous coronary intervention (pci) was performed to treat the proximal right coronary artery (rca).A 6fr guide catheter was introduced and the lesion was pre-dilated with an unspecified balloon.The xience skypoint stent was implanted and the procedure was completed.On (b)(6) 2022, the patient developed a stroke and was hospitalized.The patient subsequently recovered after the stroke.On (b)(6) 2023, the patient experienced an st elevated myocardial infarction (stemi).An unknown stent was implanted successfully in the left anterior descending (lad) artery but the patient developed thrombosis, residual emboli in the periphery and a cardiogenic shock with as (aortic stenosis).The patient was hospitalized but died on (b)(6) 2023.The physician stated the xience skypoint stent did not cause or contribute to the patient death.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.The reported patient effect of stroke are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17186851
MDR Text Key317725515
Report Number2024168-2023-06630
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233395
UDI-Public08717648233395
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1804350-15
Device Catalogue Number1804350-15
Device Lot Number203224A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/31/2023
Initial Date FDA Received06/22/2023
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/29/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Disability;
Patient Age85 YR
Patient SexFemale
Patient Weight40 KG
-
-